(1)
Mataczyna, K.; Wielgórska-Leszczyńska, J. Information on Intellectual Capital in the Financial Statements and Annual Activity Reports of Pharmaceutical Companies. KREM 2020, No. 3(987), 107-125. https://doi.org/10.15678/ZNUEK.2020.0987.0306.